Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD)
NCT ID: NCT01324791
Last Updated: 2011-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial
NCT01321294
Laparoscopic Total vs Partial Fundoplication in Patients With Atypical Symptoms of Gastroesophageal Reflux Disease
NCT05647668
Applying Long-term Follow-up to Improve Patient Selection in Laparoscopic Anti-reflux Surgery
NCT03959020
Intraoperative Endomanometric Laparoscopic Nissen Fundoplication Improves Postoperative Outcomes
NCT05851794
Laparoscopic Sleeve Gastrectomy and Gastroesophageal Acid Reflux
NCT02012894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laparoscopic antireflux surgery
anti-reflux surgery
endoscopic full-thickness-gastroplication
anti-reflux surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anti-reflux surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* persistent or recurrent symptoms despite optimal medical treatment
* persistent or recurrent complications of GERD
* reduced quality of life owing to increasing esophageal exposure to gastric juice
* pathological values in the preoperative evaluated functional parameters.
Exclusion Criteria
* dysphagia
* esophageal strictures
* poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Public Hospital Zell am See
OTHER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GPH Zell am See
Zell am See, Salzburg, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zell02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.